Carrier frequency estimation of Zellweger spectrum disorder using ExAC database and bioinformatics tools |
| |
| Institution: | 1. Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA;;2. Biomedical Informatics Research Center, Marshfield Clinic Research Foundation, Marshfield, WI, USA;;3. Biotechnology Center, University of Wisconsin–Madison, Madison, WI, United States;;4. Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA;;5. Wisconsin State Laboratory of Hygiene, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.;1. Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA;;2. Biomedical Informatics Research Center, Marshfield Clinic Research Foundation, Marshfield, WI, USA;;3. Biotechnology Center, University of Wisconsin–Madison, Madison, WI, United States;;4. Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA;;5. Wisconsin State Laboratory of Hygiene, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. |
| |
| Abstract: | PurposeWe aimed to estimate the carrier frequency of Zellweger spectrum disorder (ZSD), a rare autosomal recessive disease, and the associated disease incidence based on data from the Exome Aggregation Consortium (ExAC) of approximately 60,000 individuals.MethodsWe obtained variants from ExAC in 13 PEX genes associated with ZSD. Potentially pathogenic missense variants were identified with computational variant analysis tools according to three stringency levels. Using variants classified as potentially pathogenic, we estimated the carrier frequency and the associated incidence for the entire ExAC population and its subpopulations. We also evaluated variants based on pathogenicity criteria for sequence variant interpretation outlined by the American College of Medical Genetics and Genomics (ACMG) and calculated the carrier frequency and incidence based on those variants.ResultsThe bioinformatically estimated incidence rate of ZSD in the ExAC population is 1 in 83,841 using our least stringent pathogenicity cutoff. Under clinical guidelines outlined by ACMG, the estimated incidence is 1 in 3,275,751 births.ConclusionWe outlined a process for estimating the ZSD disease carrier frequency and incidence in a large consortium using bioinformatics tools. Our results are close to current newborn screening estimates in New York of 1 in 90,000 births, estimated from 1.08 million screenings. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
